View Older Stories View More Recent Stories
-
GrubHub Inc. (GRUB) PT Raised to $78 at Roth Capital
-
My Size Completes $6 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
-
Tetra Tech (TTEK) PT Raised to $59 at Roth Capital on 1Q Beat; 'Broad End Customer Strength'
-
Viking Therapeutics (VKTX) Prices 11M Shares at $5
-
Viking Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock
-
Roth Capital Starts CalAmp Corp. (CAMP) at Buy, 'Telematics Leader with Scale, Brand and Channel'
-
Roth Capital Starts ORBCOMM (ORBC) at Buy, Says Valuation is Attractive
-
Roth Capital Starts Digi International (DGII) at Buy, 'Emerging Leader of $3B Cold Chain Market'
-
OSI Systems (OSIS) PT Lowered to $78 at Roth Capital
-
CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Q Biomed Inc. Closes $5.48 Million Public Offering
-
One Stop Systems (OSS) IPO Opens 11% Higher
-
iPic® Entertainment Begins Trading Publicly On NASDAQ
-
iPic® Entertainment Announces Closing of its Initial Public Offering
-
One Stop Systems (OSS) Prices 3.8M IPO at $5/Share
-
One Stop Systems, Inc. Announces Pricing of Initial Public Offering
-
One Stop Systems, Inc. Announces Pricing of Initial Public Offering
-
Roth Capital Starts interCLICK (ICLK) at Buy
-
Roth Capital Starts Castle Brands Inc. (ROX) at Buy
-
Roth Capital Starts Epizyme (EPZM) at Buy
-
Pre-Open Movers 01/31: (CASC) (SFLY) (KNX) Higher; (BLCM) (MGI) (CACC) Lower (more...)
-
UPDATE: Remark Media (MARK) PT Doubled to $20.50 at Roth Capital; Potential 'AI Juggernaut', Says Share Weakness is Unfounded
-
My Size (MYSZ) Prices 3M Share Common Offering at $2/Sh
-
My Size Announces Pricing of $6.0 Million Public Offering of Common Stock and Warrants
-
Aimmune Therapeutics (AIMT) PT Raised to $75 at Roth Capital Following KOL Takeaways
-
My Size (MYSZ) Plans Offering of Common Stock, Warrants
-
My Size Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
-
Roth Capital Downgrades Callidus Software (CALD) to Neutral Following Acquisition, 'Great Exit for a Great Executor'
-
Q BioMed Inc. Prices $5.5 Million Public Offering
-
CymaBay Therapeutics (CBAY) Prices 11.6M Shares at $10.80
-
CymaBay Announces Pricing of Public Offering of Common Stock
-
Silicon Labs (SLAB) PT Raised to $110 at Roth Capital; Reiterates Buy
-
Eyenovia Announces Closing of $27.3 Million Initial Public Offering
-
Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
-
Roth Capital Starts CynergisTek (CTEK) at Buy
-
Evolution Petroleum Reports Quarterly Update on Delhi and Announces Fiscal Second Quarter 2018 Earnings Release Date
-
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
-
Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock
-
PlayAGS (AGS) IPO Opens Up 6%
-
PlayAGS Inc. (AGS) Prices 10.25M Share IPO at $16/Sh
-
AGS Prices Initial Public Offering
-
Eyenovia (EYEN) IPO Opens Flat
-
Las Vegas Sands (LVS) PT Raised to $85 at Roth Capital
-
Albireo Pharma (ALBO) Prices 1.97M Common Stock Offering at $33/Share
-
Albireo Prices $65.0 Million Public Offering of Common Stock
-
Roth Capital Assumes CymaBay Therapeutic (CBAY) at Buy
-
Eyenovia Inc. (EYEN) Prices 2.73M Share IPO at $10/Sh
-
Eyenovia Announces Pricing of Initial Public Offering
-
Albireo Pharma (ALBO) to Offer Common Stock
-
Albireo Announces Proposed Public Offering of Common Stock
